A Clinical Trial to Evaluate the Safety and Efficacy of Staged Bilateral Exablate Treatment of Medication Refractory Essential Tremor
Recruiting
99 years or below
All
5 participants needed
Brief description of study
The Exablate Model 4000 Type-1.0/1.1 Neuro system involves using an advanced, non-invasive technique currently approved by the Food and Drug Administration (FDA) to treat one side of your brain in a procedure called a thalamotomy (lesion the thalamus). This procedure involves performing an ablation (lesion) of an area of the thalamus (a region in your brain) essential for treating Essential Tremor.
While treating one side of the brain works well for patients that have a tremor dominance on one side of their body, patients that are bilaterally (both sides) affected with Essential Tremor may desire a bilateral treatment. You are being offered this study because you have been diagnosed with Essential Tremor and previously completed an Exablate Index Procedure to treat your Essential Tremor. The Exablate Index Procedure was the first Exablate procedure that was performed to treat your essential tremor on your dominant tremor side.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
Updated on
09 Apr 2021.
Study ID: 834897
Find a site
,
Your Information has been sent successfully.
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up
Send a message
Enter your contact details to connect with study team
Primary Contact
Message For Non Enrolling By Invitation Trial
Select a study center that’s convenient for you, and get in touch with the study team.
Please choose between Voice or SMS based delivery of verification code
or